A Systematic Review of carbohydrate-based Bioactive Molecules for Alzheimer’s Disease
- 2 September 2021
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 13 (19) , 1695-1711
Abstract
The abundance, low cost, high density of functional groups and ease of purification of carbohydrates are among the most important features that make them a prime candidate for designing therapeutic...Keywords
Funding Information
- Ministry of Education, New Delhi, India
- Indian Institute of Technology (BHU) Varanasi
This publication has 78 references indexed in Scilit:
- Identification of oligomers at early stages of tau aggregation in Alzheimer's diseaseThe FASEB Journal, 2012
- “Clicked” Sugar–Curcumin Conjugate: Modulator of Amyloid-β and Tau Peptide Aggregation at Ultralow ConcentrationsACS Chemical Neuroscience, 2011
- A specific inhibitory effect of multivalent trehalose toward Aβ(1-40) aggregationPolymer Chemistry, 2011
- Carbohydrate chemistry in drug discoveryOrganic & Biomolecular Chemistry, 2011
- Tau protein and tau aggregation inhibitorsNeuropharmacology, 2010
- Discovery and design of carbohydrate-based therapeuticsExpert Opinion on Drug Discovery, 2010
- Acetylcholinesterase inhibitory activity of novel chitooligosaccharide derivativesCarbohydrate Polymers, 2009
- Mechanisms of tau-induced neurodegenerationActa Neuropathologica, 2009
- Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42Neurobiology of Disease, 2005
- Carbohydrate-based therapeuticsJournal of Pharmacy and Pharmacology, 2004